<DOC>
	<DOC>NCT01221584</DOC>
	<brief_summary>The purpose of the study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the All-Russian Scientific Cardiology Society guidelines/ the 4th Joint European Task Force guidelines.</brief_summary>
	<brief_title>Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Subject must be 18 years of age or older of either gender or race. Subject must provide informed consent and comply with the survey procedures. Subject is on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks. Subjects who are unwilling or unable to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Dyslipidaemia</keyword>
	<keyword>LDL-C goals</keyword>
	<keyword>guidelines</keyword>
</DOC>